<code id='366B2CDC4A'></code><style id='366B2CDC4A'></style>
    • <acronym id='366B2CDC4A'></acronym>
      <center id='366B2CDC4A'><center id='366B2CDC4A'><tfoot id='366B2CDC4A'></tfoot></center><abbr id='366B2CDC4A'><dir id='366B2CDC4A'><tfoot id='366B2CDC4A'></tfoot><noframes id='366B2CDC4A'>

    • <optgroup id='366B2CDC4A'><strike id='366B2CDC4A'><sup id='366B2CDC4A'></sup></strike><code id='366B2CDC4A'></code></optgroup>
        1. <b id='366B2CDC4A'><label id='366B2CDC4A'><select id='366B2CDC4A'><dt id='366B2CDC4A'><span id='366B2CDC4A'></span></dt></select></label></b><u id='366B2CDC4A'></u>
          <i id='366B2CDC4A'><strike id='366B2CDC4A'><tt id='366B2CDC4A'><pre id='366B2CDC4A'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:164
          Thomas Massie -- health policy coverage from STAT
          Rep. Thomas Massie (R-Ky.) Kevin Dietsch/Getty Images

          WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health.

          The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

          advertisement

          The spending bill already included a restriction on funding this research in any country determined to be a “foreign adversary,” including China. Scientists at the Wuhan Institute of Virology studied gain-of-function in some viruses, fueling theories that the Covid-19 pathogen was a lab leak. Those theories have never definitively been proven.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Medicare coverage of Wegovy, once blocked, now looks possible
          Medicare coverage of Wegovy, once blocked, now looks possible

          SteffenTrumpf/picturealliance/GettyImagesWASHINGTON— NovoNordisk’snewlywonpermissiontomarkettheheart

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Hospitals are piloting generative AI tools as regulators play catch

          AdobeUsuallythewordsgenerativeAIinhealtharefollowedbyaboldclaim.Thetechnologywilltransformsomeaspect